Vamifeport
Vamifeport (VIT-2763) is a novel orally active inhibitor that targets iron transport proteins and reduces markers of hemolysis in the SCD Townes model.VIT-2763 improves anemia and erythropoiesis, ameliorates vascular inflammation, and can be studied in β-thalassemia.
Product Specifications
CAS Number
2095668-10-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
408.43
Molecular Formula
C21H21FN6O2
Notes
Research use only, not for human use.
Receptor
Ferroptosis
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1367112-01 0.02 mg (E-Coli)
Recombinant Burkholderia xenovorans tRNA 2-thiocytidine biosynthesis protein TtcA (ttcA)
Ask
View Details MBS1367112-02 0.02 mg (Yeast)
Recombinant Burkholderia xenovorans tRNA 2-thiocytidine biosynthesis protein TtcA (ttcA)
Ask
View Details MBS1367112-03 0.1 mg (E-Coli)
Recombinant Burkholderia xenovorans tRNA 2-thiocytidine biosynthesis protein TtcA (ttcA)
Ask
View Details 
MBS1367112-04 0.1 mg (Yeast)
Recombinant Burkholderia xenovorans tRNA 2-thiocytidine biosynthesis protein TtcA (ttcA)
Ask
View Details MBS1367112-05 0.02 mg (Baculovirus)
Recombinant Burkholderia xenovorans tRNA 2-thiocytidine biosynthesis protein TtcA (ttcA)
Ask
View Details MBS1367112-06 0.02 mg (Mammalian-Cell)
Recombinant Burkholderia xenovorans tRNA 2-thiocytidine biosynthesis protein TtcA (ttcA)
Ask
View Details